21 – 30 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients
(
- Contribution to journal › Article
-
Mark
Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
De novo lupus nephritis during treatment with belimumab
(
- Contribution to journal › Article
-
Mark
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Contributions of de novo variants to systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Interaction between the STAT4 rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
(
- Contribution to journal › Article
-
Mark
Variants in BANK1 are associated with lupus nephritis of European ancestry
(
- Contribution to journal › Article
-
Mark
Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing
(
- Contribution to journal › Article
- 2020
-
Mark
Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
(
- Contribution to journal › Article